DK118682A - Anigiotropiner fra leucocyter og inflammationsvaev samt fremgangsmaade til fremstilling deraf - Google Patents

Anigiotropiner fra leucocyter og inflammationsvaev samt fremgangsmaade til fremstilling deraf Download PDF

Info

Publication number
DK118682A
DK118682A DK118682A DK118682A DK118682A DK 118682 A DK118682 A DK 118682A DK 118682 A DK118682 A DK 118682A DK 118682 A DK118682 A DK 118682A DK 118682 A DK118682 A DK 118682A
Authority
DK
Denmark
Prior art keywords
anigiotropines
leucocytes
procedures
producing
tissue
Prior art date
Application number
DK118682A
Other languages
English (en)
Inventor
J H Wissler
W Schaper
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of DK118682A publication Critical patent/DK118682A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/515Angiogenesic factors; Angiogenin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK118682A 1981-03-18 1982-03-17 Anigiotropiner fra leucocyter og inflammationsvaev samt fremgangsmaade til fremstilling deraf DK118682A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3110560A DE3110560A1 (de) 1981-03-18 1981-03-18 "angiotropine der leukozyten und des entzuendungsgewebes: eine neue klasse natuerlicher chemotropischer mitogene fuer das richtungswachstum von blutgefaessen und zur neovaskularisierung von geweben"

Publications (1)

Publication Number Publication Date
DK118682A true DK118682A (da) 1982-09-19

Family

ID=6127640

Family Applications (1)

Application Number Title Priority Date Filing Date
DK118682A DK118682A (da) 1981-03-18 1982-03-17 Anigiotropiner fra leucocyter og inflammationsvaev samt fremgangsmaade til fremstilling deraf

Country Status (8)

Country Link
US (1) US4465669A (da)
EP (1) EP0061138B1 (da)
JP (1) JPS57206621A (da)
AT (1) ATE17858T1 (da)
AU (1) AU550434B2 (da)
CA (1) CA1188244A (da)
DE (2) DE3110560A1 (da)
DK (1) DK118682A (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3586355T2 (de) * 1984-11-29 1993-01-14 Univ Minnesota Heilmittel fuer wunden.
US5165938A (en) * 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
US4727137A (en) * 1985-04-17 1988-02-23 President And Fellows Of Harvard College Purified protein having angiogenic activity and methods of preparation
EP0248088A4 (en) * 1985-11-22 1988-05-03 Teijin Ltd VASCULARIZATION FACTOR AND MANUFACTURING.
US5026839A (en) * 1985-12-17 1991-06-25 Synergen, Inc DNA encoding a basic fibroblast growth factor
ATE107315T1 (de) * 1985-12-17 1994-07-15 Synergen Inc Menschlicher plazentarer angiogenischer faktor, geeignet für die reizung der kapillarsynthese, der endothelzellprotease, der dns-synthese und der absiedlung.
US4994559A (en) * 1985-12-17 1991-02-19 Synergen, Inc. Human basic fibroblast growth factor
US4808402A (en) * 1987-05-29 1989-02-28 Northwestern University Method and compositions for modulating neovascularization
US4853219A (en) * 1987-08-06 1989-08-01 President And Fellows Of Harvard College Antibodies to angiogenin: immunotherapeutic agents
US6077823A (en) * 1991-03-11 2000-06-20 Creative Biomolecules, Inc. Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
US6395883B1 (en) * 1991-03-11 2002-05-28 Curis, Inc. Soluble morphogenic protein complex compositions of matter
US5494808A (en) * 1994-09-15 1996-02-27 Merck & Co., Inc. Defined medium OMPC fermentation process
DE69740089D1 (de) 1996-03-22 2011-02-10 Stryker Corp Verfahren zur verbesserten funktionellen Erholung der motorischen Koordiination, der Sprache oder der Sinneswahrnehmung nach Trauma oder Ischämie des ZNS
US20080199513A1 (en) * 1997-06-24 2008-08-21 Cascade Medical Enterprises, Llc Systems and methods for preparing autologous fibrin glue
US6979307B2 (en) * 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
US7745106B2 (en) * 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
DE19810998C1 (de) * 1998-03-13 1999-08-26 Fraunhofer Ges Forschung Metallhaltige Ribonukleotidpolypeptide
AU2763099A (en) 1998-06-22 2000-01-10 Charles E. Worden Enriched platelet wound healant
US6783987B2 (en) * 1999-12-09 2004-08-31 Tsukasa Matsumoto Method for obtaining components from cultured leucocyte
US6663859B2 (en) * 2000-01-07 2003-12-16 Bioenergy, Inc. Compositions for enhancing the immune response
AUPR177300A0 (en) * 2000-11-29 2000-12-21 Centre For Molecular Biology And Medicine Therapeutic methods
US7481790B2 (en) * 2000-12-27 2009-01-27 Advanced Cardiovascular Systems, Inc. Vessel enlargement by arteriogenic factor delivery
NL1019368C2 (nl) * 2001-11-14 2003-05-20 Nutricia Nv Preparaat voor het verbeteren van receptorwerking.
WO2006102488A1 (en) * 2005-03-22 2006-09-28 Cascade Medical Enterprises, Llc Systems and methods of producing membranes
RU2009106083A (ru) * 2006-09-08 2010-10-20 Вайет (Us) Аргининовая промывка для очистки белков с использованием аффинной хроматографии

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2722769C3 (de) * 1977-05-20 1981-08-06 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verwendung von Fibrinogen
US4229531A (en) * 1978-12-29 1980-10-21 Monsanto Company Production of tumor angiogenesis factor by cell culture

Also Published As

Publication number Publication date
EP0061138A2 (en) 1982-09-29
ATE17858T1 (de) 1986-02-15
CA1188244A (en) 1985-06-04
US4465669A (en) 1984-08-14
DE3268915D1 (en) 1986-03-20
EP0061138A3 (en) 1983-09-07
AU550434B2 (en) 1986-03-20
EP0061138B1 (en) 1986-02-05
DE3110560A1 (de) 1982-10-14
JPS57206621A (en) 1982-12-18
AU8163382A (en) 1982-09-23

Similar Documents

Publication Publication Date Title
DK118682A (da) Anigiotropiner fra leucocyter og inflammationsvaev samt fremgangsmaade til fremstilling deraf
AU578050B2 (en) Desulfatohirudins, the preparation thereof and pharmaceutical compositions containing them
AU2815589A (en) Method for the delivery of genetic material across the blood brain barrier
NO820090L (no) Fremgangsmaate for fremstilling og behandling av renninderivater
MY8700761A (en) Novel antihistamines process for their preparation and pharmaceutical compositions containing them
IT8220946A0 (it) Procedimento per preparare composizioni di enzimi coagulanti del sangue
DK540685D0 (da) Blodpladepeptidbeslaegtet vaekstregulator
AU550626B2 (en) Chemokinesins and chemotaxins of leucocytes and inflamed tissues
IL81370A (en) Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
FI885031A (fi) Vaextregulator av blodplaettetyp.
ATE77239T1 (de) Zubereitung zur stimulation der chondrozyten und des osteoblastes (ossein-hydroxyapatitverbindung), verfahren zur herstellung und pharmazeutische produkten, die sie enthalten.
DK118882A (da) Mitogener fra leucocyter og inflammationsvaev samt fremgangsmaade til fremstilling deraf
DK118782A (da) Kemorecruitiner fra leucocyter og inflammationsvaev samt fremgangsmaade til fremstilling deraf
SE8105340L (sv) Nya 4-karbamoyloxioxazafosforiner samt forfarande for framstellning derav
FR2492384B1 (fr) Procede de preparation de nouveaux composes cytostatiques et compositions pharmaceutiques les contenant
UA5743C2 (uk) Препарат тканинних біологічно активних речовин, який має регенаторну дію, та спосіб його одержання
IT1209508B (it) Nuovi medicinali per il trattamento di malattie cardiache.
IT8402909A0 (it) Procedimento per la preparazione del prodotto farmaceutico o-acetil-1-carnitina cloruro.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment